Back to Search

ALYSSA VILLANUEVA, MD

MD

Pediatrics Physician

NPI: 1386492031Individual

Specialties, Licenses & Credentials

Pediatrics PhysicianPrimary

Pediatrics

Code: 208000000X

BP10088349(TX)

Research & Publications (20)

A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.
PMID 19234449·Nat Biotechnol·2009
7-preclinical
PRL-3 overexpression in epithelial cells is induced by surrounding stromal fibroblasts.
PMID 19586538·Mol Cancer·2009
8-other
Pathogenesis of hepatocellular carcinoma and molecular therapies.
PMID 19387255·Curr Opin Gastroenterol·2009
6-review
Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
PMID 19417025·Clin Cancer Res·2009
7-preclinical
Improving images of fluorescent cell labeling by background signal subtraction.
PMID 19267289·Biotech Histochem·2009
8-other
Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area.
PMID 19295473·Shock·2009
7-preclinical
Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer.
PMID 19325125·Proc Natl Acad Sci U S A·2009
7-preclinical
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression.
PMID 19221438·J Clin Invest·2009
7-preclinical
The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells.
PMID 19420433·Nanotechnology·2009
8-other
Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).
PMID 19195847·Eur Psychiatry·2009
4-observational
Molecular profiling to predict hepatocellular carcinoma outcome.
PMID 19351279·Expert Rev Gastroenterol Hepatol·2009
8-other
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo.
PMID 19665249·J Hepatol·2009
7-preclinical
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
PMID 18701503·Cancer Res·2008
8-other
PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness.
PMID 19002188·Br J Cancer·2008
7-preclinical
Evaluation of corneal refraction in a model of a gaze tracking system.
PMID 19126462·IEEE Trans Biomed Eng·2008
8-other
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
PMID 18923165·N Engl J Med·2008
8-other
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling.
PMID 18852116·Mol Cancer Ther·2008
6-review
A microRNA DNA methylation signature for human cancer metastasis.
PMID 18768788·Proc Natl Acad Sci U S A·2008
7-preclinical
[Laparoscopic appendectomy after the learning curve].
PMID 18756872·Cir Pediatr·2008
8-other
Pivotal role of mTOR signaling in hepatocellular carcinoma.
PMID 18929564·Gastroenterology·2008
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
1501 RED RIVER ST FL 2
AUSTIN, TX 78712

Location

Practice Location

1501 RED RIVER ST FL 2, AUSTIN, TX
(512) 495-5555

Quick Facts

NPI
1386492031
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile